Leonardo DRS vs L3Harris Technologies
DRS and LHX side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DRS and LHX compare
L3Harris Technologies is the larger company, worth 5.4 times as much as Leonardo DRS ($48.5B against $9.0B).
On earnings, L3Harris Technologies is cheaper: it trades at 24.3× trailing earnings, against 24.8× for Leonardo DRS.
Leonardo DRS grew revenue faster over the last twelve months (8.9% versus 5.3% for L3Harris Technologies).
Leonardo DRS keeps more of each dollar of sales as profit, with a net margin of 9.4% compared with 5.2% at L3Harris Technologies.
Both pay dividends: Leonardo DRS yields 1.3% and L3Harris Technologies 1.4%.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DRS | LHX |
|---|---|---|
| Size and price | ||
| Market cap | $9.0B | $48.5B |
| Share price | $33.71 | $260.74 |
| Change, 1 year | −3.2% | −9.9% |
| Change, 5 years | 241% | 21.2% |
| Beta (5Y) | 0.78 | 0.45 |
| Employees | 7,300 | 45K |
| StockData Score | ||
| Total score | 19 | 19 |
| Valuation score | 5 | 6 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 4 (better) | 3 |
| Health score | 5 (better) | 3 |
| Dividend score | 1 | 4 (better) |
| Valuation | ||
| P/E | 24.8× | 24.3× (better) |
| P/S | 2.3× | 1.2× (better) |
| P/B | 3.1× | 2.4× (better) |
| EV/EBITDA | 17.0× | 10.6× (better) |
| P/FCF | 26.1× | 13.3× (better) |
| PEG | – | 1.54 |
| FCF yield | 3.8% | 7.5% (better) |
| Fair value | $41.48 | $357.80 |
| Margin of safety | 18.7% | 27.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 8.9% (better) | 5.3% |
| Revenue growth, 5Y average | 5.6% | – |
| Net income growth (TTM) | 37.7% (better) | 16.2% |
| EPS growth (TTM) | 38.8% (better) | 15.1% |
| EPS growth, 5Y average | 20.8% (better) | 1.6% |
| Profitability | ||
| Gross margin | 25.3% | 25.6% (better) |
| Operating margin | 10.8% (better) | 10.6% |
| Net margin | 9.4% (better) | 5.2% |
| FCF margin | 8.9% | 9.2% (better) |
| Return on equity | 13.2% (better) | 10.3% |
| Return on invested capital | 13.5% (better) | 12.8% |
| Financial health | ||
| Debt / equity | 0.06 (better) | 0.54 |
| Net debt / EBITDA | −0.23 | 1.49 (better) |
| Current ratio | 1.88 (better) | 1.20 |
| Altman Z-score | 4.46 (better) | 2.72 |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 1.3% | 1.4% (better) |
| Payout ratio | – | 45.5% |
| Years of dividend growth | 0 | 4 (better) |
| Buyback yield | 0.34% | 1.6% (better) |
| Shareholder yield | 1.7% | 3.0% (better) |
| Ownership | ||
| Held by institutions | 26.6% | 87.9% |
| Held by insiders | 0.31% | 0.32% |
| Insider net buying, 12 months | −$8.6M | −$7.5M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 1.5% | 2.2% |
Go deeper
- DRS stock overview
- DRS income statement
- DRS valuation and score
- LHX stock overview
- LHX income statement
- LHX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.